Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05315297 · ClinicalTrials.gov registry record · NA

Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis

A NA study of Thumb Osteoarthritis, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
61
Enrollment target
1
Study location

NCT05315297: Completed NA study of Thumb Osteoarthritis, sponsored by Stanford University.

NCT05315297 is a NA study of Thumb Osteoarthritis that has completed, run by Stanford University. The registered enrollment target is 61 participants, below the 111-participant average among 4 other Thumb Osteoarthritis trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05315297, a NA study of Thumb Osteoarthritis, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
61 participants
Enrollment target
1
Study location

Study Summary

Long-Term Objective: Determine if high-frequency PEMF therapy reduces pain in patients with thumb carpometacarpal (CMC) joint osteoarthritis (OA). Study Design and Methods: This will be a randomized controlled pilot study with 60 subjects with CMC OA randomly divided in two groups. Thirty subjects will receive high-frequency PEMF therapy overlying the CMC joint overnight daily for four weeks. The other 30 subjects will receive a sham PEMF therapy device applied to the same joint overnight daily for four weeks. Pain and function questionnaires will be obtained for all patients at enrollment, four weeks, and six weeks.

Primary Outcome

NPRS is a unidimensional measure of pain intensity in adults. The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

Conditions Studied

Interventions

  • DEVICE PEMF device
  • DEVICE Sham PEMF device

Study Locations (1)

California

  • Stanford Medicine Outpatient Center - Redwood City

Trial Details

FieldValue
Enrollment Target 61 participants
Start Date 2023-06-20
Est. Completion 2024-08-31
Phase NA
Stanford University

1,744 total trials

What the finished NCT05315297 record still lists

NCT05315297 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 61 participants, a relatively small participant target, below the 111-participant average among 4 other Thumb Osteoarthritis trials with a reported enrollment target (45% lower).

The record links to 1 condition, with Thumb Osteoarthritis appearing as the primary indexed condition, and to 2 interventions - of which PEMF device is the first listed.

NCT05315297 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT05315297 about?

NCT05315297 is a clinical study titled "Pulsed Electromagnetic Field (PEMF) Therapy in Thumb CMC Arthritis". Long-Term Objective: Determine if high-frequency PEMF therapy reduces pain in patients with thumb carpometacarpal (CMC) joint osteoarthritis (OA). Study Design and Methods: This will be a randomized controlled pilot study with 60 subjects with CMC OA randomly divided in two groups. Thirty subjects ...

What is the current status of trial NCT05315297?

This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2023-06-20. Estimated completion is 2024-08-31.

What conditions does trial NCT05315297 study?

This clinical trial studies the following conditions: Thumb Osteoarthritis.

What interventions are being tested in trial NCT05315297?

The interventions under investigation include: PEMF device (DEVICE), Sham PEMF device (DEVICE).

Who is sponsoring clinical trial NCT05315297?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05315297 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thumb Osteoarthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04115306 · 61 participants · Phase 1

    Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer

  • NCT05070845 · 61 participants · Phase 2

    Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia

  • NCT05187832 · 61 participants · Phase 1

    A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer

  • NCT05269316 · 61 participants · Phase 1

    Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05315297, the US trial registry maintained by the National Library of Medicine. NCT05315297 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.